ECOLE NATIONALE VÉTÉRINAIRE DE TOULOUSE
🏢 View company profile →3Patents
3Active
3Granted
43Portfolio score
Filing activity: Jun 11, 2010 → Jul 7, 2020 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8613915B2 | Attenuated strain of myxoma virus for use as an oncolytic drug | Chemistry; Metallurgy | 0 | Active |
| US11912645B2 | Lipopeptide compounds for the treatment of pain disorders | Human Necessities | 0 | Active |
| US12011466B2 | Modified Escherichia coli strain Nissle and treatment of gastrointestinal disorder | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.